Shared from parkinsonsnewstoday.com. Early treatment with the investigational small molecule golexanolone improved motor and cognitive function and eased signs of fatigue, anxiety, and depression in a rat model of Parkinson’s disease. The Umecrine...
Shared from parkinsonsnewstoday.com. Most molecular features in the human brain differ between samples obtained from living individuals and those collected after death, according to new findings from the Living Brain Project, a multiscale investigation from The...
Shared from verywellhealth.com. A study of the health records of over a million people in East London has identified two conditions that might be early symptoms of Parkinson’s disease: hearing loss and epilepsy.1 Recognizing these as possible signs of Parkinson’s...
Shared from parkinsonsnewstoday.com. Deep brain stimulation (DBS) can provide lasting relief from motor symptoms and help people with Parkinson’s disease function better day to day over time, while reducing the need for medication, according to a study led by...
Shared from parkinsonsnewstoday.com. Brain damage in Parkinson’s disease may be driven in part by certain nerve cells working too hard, causing them to accrue damage and die. This suggests that treatments that reduce the activity of these cells may help slow the...
Shared from neurologyadvisor.com Golf courses are often heavily treated with pesticides, the exposure to which is considered a potential environmental risk factor for PD. To better understand the role of golf course pesticide exposure in PD risk, researchers...
